Skip to main content
. 2019 Apr 3;11(4):776. doi: 10.3390/nu11040776

Table 2.

Clinical chemistry parameters after dosing with dGTE for 24 h and 2 weeks.

24 h Units Vehicle 1X 3X 10X
Total Bilirubin mg/dL <0.2 <0.2 <0.2 <0.2
ALT U/L 28.8 (±8.8) 52.6 (±20.2) 34.4 (±14.8) 32.2 (±11.9)
AST U/L 66.2 (±5.7) 84.2 (±8.2) 65.2 (±9.8) 68.2 (±10.3)
GGT U/L <3.0 <3.0 <3.0 <3.0
Alkaline Phosphatase IU/L 197 (±3.8) 196.2 (±7.3) 163.8 (±13.5) * 189.8 (±6.4)
2 weeks Units Vehicle 1X 3X 10X
Total Bilirubin mg/dL <0.2 <0.2 0.2 <0.2
ALT U/L 28.8 (±8.8) 24.8 (±2.3) 34.2 (±14.4) 33.5 (±11.6)
AST U/L 66.2 (±5.7) 49.2 (±12.9) 70.8 (±13.9) 67.6 (±10.4)
GGT U/L <3.0 4.8 (±1.3) <3.0 <3.0
Alkaline Phosphatase IU/L 148 (±4.5) 91.6 (±12.9) ** 131.2 (±18.1) 140.2 (±6.7)

Data presented as mean +/- SEM (n = 5 per group) * p < 0.05, ** p < 0.01 compared to vehicle.